premier scientific program keynote speakers invited ... · hcs/hca colloquium coordinator ann f....

2
PREMIER SCIENTIFIC PROGRAM Invited Speakers Announced Advanced Cell Model Systems The OrganoPlate: Human organ-on-a-chip tissue models for predictive drug testing in any throughput. Jos Joore, Mimetas, Netherlands. 3D bioprinting and iPS cells help generate patient-specific ocular tissue to model and treat age related macular de- generation. Kapil Bharti, National Eye Institute, NIH. Phenotypic Drug Discovery Vascularized MicroTumors: A platform for phenotypic drug discovery and validation. Chris Hughes, Univ of CA, Irvine. High throughput and high content assays and screens for mitochondrial function and dynamics in neurons. Ron Davis, The Scriptts Research Institutes, FL. Informatics & Image Analysis From pixels to phenotypes: Deep learning for analyzing high-content cellular images. William Godinez, Novartis. Identification of therapeutics for rare genetic diseases using phenotypic signatures. Yolanda Chong, Recursion Pharm. New Technologies Control of cell polarity, adhesion and germinal zone exit during neuronal progenitor differentiation. David Solecki, St. Jude Children's Research Hospital, Memphis, TN. A new FLIM-FRET instrument with hyperspectral imaging for quantitative high content screening. Christian Tardif, Biophotonics Program Institute Nationale Optic, Quebec. EDUCATIONAL COURES Hardware & Image Acquisition; Assay Develop- ment; Image & Data Analysis. Assay Validation; RNAi; Tissue based imaging; CellProfiler; Machine Learning; Effect-Size Measures as Descriptors of HCS Assay Quality; CRISPR, and more. SBI 2 HCS/HCA COLLOQUIUM Emerging Technologies in Biological Mod- els, When & Why? A guided roundtable discus- sion focused on best practices and solutions from challenges & unmet needs in high content imaging. ©2017 Society of Biomolecular Imaging and Informatics, P.O. Box 12300, Research Triangle Park, NC 27709 KEYNOTE SPEAKERS Dr. Brenda J. Andrews “Automated analysis of high- content microscopy data”. Charles H. Best Chair of Medical Research Director, Professor, Department of Molecular Genetics, University of Toronto Dr. Richard Caprioli “Imaging Mass Spectrometry: Molecular Microscopy for Biol- ogy and Medicine” . Stanford Moore Chair in Biochemistry, Chemistry, Pharmacology & Medicine, School of Medicine, Vanderbilt University. Abstract Deadlines Platform Oral Presentations: Monday, July 31, 2017 Poster Presentations: Friday, August 25, 2017 For more details visit www.sbi2.org

Upload: others

Post on 14-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PREMIER SCIENTIFIC PROGRAM KEYNOTE SPEAKERS Invited ... · HCS/HCA Colloquium Coordinator Ann F. Hoffman (GSK) Marketing Contacts Paul A. Johnston (University of Pittsburgh) & Kaylene

PREMIER SCIENTIFIC PROGRAM Invited Speakers Announced

Advanced Cell Model Systems The OrganoPlate: Human organ-on-a-chip tissue models

for predictive drug testing in any throughput. Jos Joore, Mimetas, Netherlands.

3D bioprinting and iPS cells help generate patient-specific ocular tissue to model and treat age related macular de-generation. Kapil Bharti, National Eye Institute, NIH.

Phenotypic Drug Discovery Vascularized MicroTumors: A platform for phenotypic drug

discovery and validation. Chris Hughes, Univ of CA, Irvine. High throughput and high content assays and screens for

mitochondrial function and dynamics in neurons. Ron Davis, The Scriptts Research Institutes, FL. Informatics & Image Analysis From pixels to phenotypes: Deep learning for analyzing

high-content cellular images. William Godinez, Novartis. Identification of therapeutics for rare genetic diseases using

phenotypic signatures. Yolanda Chong, Recursion Pharm. New Technologies Control of cell polarity, adhesion and germinal zone exit

during neuronal progenitor differentiation. David Solecki, St. Jude Children's Research Hospital, Memphis, TN.

A new FLIM-FRET instrument with hyperspectral imaging for quantitative high content screening. Christian Tardif, Biophotonics Program Institute Nationale Optic, Quebec.

EDUCATIONAL COURES

Hardware & Image Acquisition; Assay Develop-

ment; Image & Data Analysis. Assay Validation;

RNAi; Tissue based imaging; CellProfiler; Machine

Learning; Effect-Size Measures as Descriptors of

HCS Assay Quality; CRISPR, and more.

SBI2 HCS/HCA COLLOQUIUM

Emerging Technologies in Biological Mod-

els, When & Why? A guided roundtable discus-sion focused on best practices and solutions from

challenges & unmet needs in high content imaging.

©2017 Society of Biomolecular Imaging and Informatics, P.O. Box 12300, Research Triangle Park, NC 27709

KEYNOTE SPEAKERS

Dr. Brenda J. Andrews

“Automated analysis of high-content microscopy data”. Charles H. Best Chair of Medical Research Director, Professor, Department of Molecular Genetics, University of Toronto

Dr. Richard Caprioli

“Imaging Mass Spectrometry: Molecular Microscopy for Biol-ogy and Medicine” . Stanford Moore Chair in Biochemistry, Chemistry, Pharmacology & Medicine, School of Medicine, Vanderbilt University.

Abstract Deadlines Platform Oral Presentations: Monday, July 31, 2017 Poster Presentations: Friday, August 25, 2017 For more details visit www.sbi2.org

Page 2: PREMIER SCIENTIFIC PROGRAM KEYNOTE SPEAKERS Invited ... · HCS/HCA Colloquium Coordinator Ann F. Hoffman (GSK) Marketing Contacts Paul A. Johnston (University of Pittsburgh) & Kaylene

* Educational courses, scientific session titles & specific times subject to change

WEDNESDAY SEPTEMBER 13th

, 2017

Registration 8:00AM-5:00PM

Introduction to HCS/HCA Training Courses 9:00AM-NOON

Advanced HCS/HCA Training Courses 9:00AM-3:00PM

SBI2 HCS/HCA Colloquium 3:00PM-6:00PM

Exhibitor Setup 4:00PM-6:00PM

Opening Reception & Networking 6:00PM-7:00PM

THURSDAY SEPTEMBER 14th

, 2017

Registration 8:00AM-5:00PM

Breakfast Technology Workshop 8:00AM-8:45AM

Introduction and Welcome 9:00AM-9:10AM

Opening Keynote 9:10AM-10:00AM

Session I: Advanced Cell Model Systems 10:10AM-12:30PM

Lunchtime Technology Workshop 12:45PM-1:30PM

Session II: Phenotypic Drug Discovery 1:50PM-4:55PM

SBI2 Annual General Business Meeting 5:00PM-5:30PM

Reception & Networking 5:30PM-6:30PM

FRIDAY SEPTEMBER 15th

, 2017

Registration 8:00AM-5:00PM

Breakfast Technology Workshop 8:00AM-8:45AM

Introduction and Welcome 9:00AM-9:10AM

Session III: Informatics 9:10AM-12:15AM

Lunchtime Poster Session 12:30PM-1:15PM

Session IV: New Technologies 1:30PM-4:00PM

Closing Keynote 4:00AM-5:00PM

Poster Awards & Close of Meeting 5:00AM-5:30PM

Scientific Program &

Organizing Committees Scientific Program Co-Chairs

O. Joseph Trask (PerkinElmer), & Daniel R. Rines (Vala Sciences).

Education & Short Courses

Debra Nickischer (Pfizer), & Doug Bowman (Takeda)

HCS/HCA Colloquium Coordinator

Ann F. Hoffman (GSK)

Marketing Contacts

Paul A. Johnston (University of Pittsburgh) &

Kaylene Simpson (Peter MacCallum Cancer Centre, Melbourne, Australia)

Program Overview (Proposed)

Registration Overview

Before Aug 1 After Aug 1

Member – Professional $350 $450

Member – Student $150 $250

Member – Vendor $400 $500

Non-Member – Professional* $450 $550

Non-Member – Student* $250 $350

Non-Member – Vendor* $500 $600

For more information please visit www.sbi2.org or email us at [email protected]

SBI2 Mission —> SBI2 is an international community of leaders, scientists, & students

promoting technological advancement, discovery, & education to

quantitatively interrogate biological models to provide high context

information at the cellular level. At this 4th annual conference it is

SBI2’s goal to build on our previous successes and continue to offer

the scientific community a high value, low cost meeting with world-

class experts in the field that teach introductory & advanced educa-

tional courses, organize a premier scientific program, and provide

forums for discussion & networking.

Quote from 2016 SBI2

Keynote

Steven Finkbeiner, M.D., Ph.D. Profes-

sor, Departments of Neurology & Physiology, UCSF, Senior Investigator & Associate Direc-tor, Gladstone Institute of Neurological Dis-ease; Director Taube/Koret Center for Neuro-

degenerative Disease Research. “I travel about 200,000 miles a year, and this is one of the most stimulating meetings I have attended the last couple years for our work”

©2017 Society of Biomolecular Imaging and Informatics, P.O. Box 12300, Research Triangle Park, NC 27709